472 filings
Page 3 of 24
8-K
pjla3eortmsrt5pqoj
4 Mar 22
Departure of Directors or Certain Officers
4:45pm
8-K
yj5rmf j1p8
24 Feb 22
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
4:11pm
8-K
5pjr85os 7a
15 Feb 22
OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance
4:45pm
8-K
a4fndz iz
22 Dec 21
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
4:45pm
8-K
6romcmg
15 Nov 21
Results of Operations and Financial Condition
4:45pm
8-K
2bgh kaje
10 Nov 21
OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased
8:00am
8-K
jtluni6j5y l3nj6
19 Oct 21
Departure of Directors or Certain Officers
4:45pm
8-K
fd6n5b
30 Sep 21
OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer
4:45pm
8-K
u7t29rb 2u
29 Sep 21
Other Events
4:30pm
8-K
y9meemszprpkz4w6kmw9
14 Sep 21
OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions
4:15pm
8-K
6tj9prn ahd0oeh
8 Sep 21
Other Events
4:15pm
8-K
l78irtygcn dmwn
7 Sep 21
OptimizeRx Recognized as a Finalist in Questex’s Fierce Pharma Marketing Awards 2021
4:15pm
8-K
aibfrpq1elwrnj
1 Sep 21
OptimizeRx to Present at Upcoming September Investor Conferences
4:30pm
S-8
b87kbxqv09ia
31 Aug 21
Registration of securities for employees
5:18pm
S-8 POS
v3vjzmngx kpci1g7lg0
31 Aug 21
Registration of securities for employees (post-effective amendment)
4:00pm
8-K
kd3ht69vskzp6q41x435
31 Aug 21
Other Events
3:59pm
8-K
tnaipmd7omfr85
25 Aug 21
Departure of Directors or Certain Officers
4:45pm
8-K
gruf4665x5hqda8vt
17 Aug 21
The Companies’ combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction
4:15pm